期刊文献+

肾动脉硬化性狭窄的预测模型研究

Study of Predictive Model for Atherosclerotic Renal Artery Stenosis in Patients with Coronary Artery Disease
下载PDF
导出
摘要 目的:探讨动脉硬化性肾动脉狭窄(ARAS)的独立危险因素及预测因子,建立在冠心病(CAD)患者中筛查ARAS的预测模型。方法:选择经肾动脉造影确诊的ARAS患者232例为ARAS组,263例无ARAS者为对照组,记录动脉硬化危险因素,测定血糖、血脂、肌酐等指标,计算内生肌酐清除率(Ccr)。采用Logistic回归分析ARAS的独立预测因子,构建筛查ARAS的预测模型,以接收者操作特征曲线(ROC)分析模型的预测价值。结果:老龄(Age,≥65岁)、糖尿病(DM)、难治性高血压(RH)、Ccr降低(≤90ml/min)是ARAS的独立预测因子,Logistic回归方程为P/(1-P)=EXP(-1.87+1.17Age+1.87RH+0.58DM+0.70Ccr),预测ARAS的最佳概率值是0.41(敏感度78.4%,特异度71.1%),ROC曲线下面积为0.80。结论:年龄≥65岁、DM、RH、Ccr降低是CAD患者并发ARAS的独立预测因子,由这些独立预测因子拟合的预测模型可用于在CAD患者中筛查ARAS。 Objective:To investigate the predictors of atherosterotic renal artery stenosis(ARAS) in patients with coronary artery disease(CAD).Method:Serum creatinine was measured in 495 patients with CAD,creatinine clearance(Ccr) was estimated by Cockroft-Gault formula.Clinical characteristics and risk factors for CAD were recorded for each patient.All patients were divided into 2 groups based upon angiographic findings.ARAS group comprised 232 patients with renal artery stenosis,and 263 patients with CAD only served as control group.Logistic regression analysis was used to determine the power of each variable for predicting ARAS in patients with CAD.The value of predictive model was calculated by constructing ROC curve.Results:Older age(≥65 year),DM,resistant hypertension(RH) and decreased Ccr(Ccr≤90 ml/min) were independent predictors for ARAS in patients with CAD.The logistic regression model for predicting ARAS in CAD patients was defined as:P/(1-P) =EXP(-1.87+1.17Age+1.87RH+0.58DM+0.70Ccr).The optimal probability value of regression model to predict ARAS in patients with CAD was 0.41(sensitivity 78.4%,specificity 71.1%),the area under the ROC curve was 0.80.Conclusion:Older age(≥65 year),DM,RH and decreased Ccr are independent predictors for ARAS in CAD patients.Logistic regression model which incoperated with these predictors can be used to screening for ARAS before catheterization in CAD patients.
出处 《微循环学杂志》 2009年第3期34-37,共4页 Chinese Journal of Microcirculation
关键词 动脉硬化性狭窄 肾动脉狭窄 肾素-血管紧张素-醛固酮系统 预测模型 严重并发症 ARAS 难治性高血压 心肾功能衰竭 Renal artery stenosis Atherosclerosis Coronary artery disease Predictive model
  • 相关文献

参考文献16

  • 1Safian RD, Textor SC. Renal-artery stenosis. N Engl J Med, 2001,344(6) : 431-442.
  • 2Vasan RS,Evans JC,Benjamin EJ, et al. Relations of serum aldosterone to cardiac structure: gender-related differences in the Framingham heart study. Hypertension,2004,43(5):957-962.
  • 3Johansson M, Elam M, Rundqvist B, et al. Increased sympathetic nerve activity in renovascular hypertension. Circulation, 1999, 99(19): 2 537-2 542.
  • 4Pimenta E, Gaddam KK, Oparil S. Mechanisms and treatment of resistant hypertension. J Clin Hypertens, 2008,10(3) : 239-244.
  • 5Harding MB, Smith LR, Himmelstein SI, et al. Renal artery stenosis: prevalence and associated risk factors inpatients undergoing routine cardiac catheterization. J Am Soc Nephrol, 1992, 2 (11): 1 608-1 616.
  • 6Van Helvoort-Postulart D, Dirksen CD, Nelemans PJ,et al. Renal artery stenosis: cost-effectiveness ofdiagnosis and treatment. Radiology, 2007,244 (2) : 505-513.
  • 7Amoroso G, Laarman GJ, Kiemeneij F. Overview of the transradial approach in percutaneous coronary intervention. J Cardiovasc Med, 2007,8(4) :230-237.
  • 8Sampson MJ, Drury PL. Accurate estimation of glomerular filtration rate in diabetic nephropathy from age, body weight, and serum ereatinine. Diabetes Care, 1992,15 (5) : 609-612.
  • 9罗海芸,蒲里津,光雪峰,白文伟,张戈,章克信.血清糖化血红蛋白及脂蛋白-(a)水平变化与糖尿病并发冠心病的关系[J].微循环学杂志,2007,17(3):39-41. 被引量:3
  • 10Paraskevas KI, Hamilton G, Cross JM, et al. Atherosclerotic renal artery stenosis: association with emerging vascular risk factors. Nephron Clin Pract, 2008,108(1) :c56-66.

二级参考文献32

  • 1[1]Wautier JL,Schmidt AM.Protein glycation:a firm link to endothelial cell dysfunction[J].Circ Res,2004,95(3):233-238.
  • 2[2]Rojas A,Morales MA.Advanced glycation and endothelial functions:a link towards vascular complications in diabetes[J].Life Sci,2004,76(7):715-730.
  • 3[3]Kalousova M,Zima T,Tesar V,et al.Advanced glycoxidation end products in chronic diseases-clinical chemistry and genetic background[J].Mutat Res,2005,579(1-2):37-46.
  • 4[4]Chavakis T,Bierhaus A,Nawroth PP.PRAGE (receptor for advanced glycation end products):a central player in the inflammatory response[J].Microbes Infect,2004,6(13):1219-1225.
  • 5[5]Basta G,Schmidt AM,de-Caterina R.Advanced glycation end products and vascular inflammation:implications for accelerated atherosclerosis in diabetes[J].Cardiovasc Res,2004,63(4):582-592.
  • 6[6]Basta G,Lazzerini G,del-Turco S,et al.At least 2 distinct pathways generating reactive oxygen species mediate vascular cell adhesion molecule-1 induction by advanced glycation end products[J].Arterioscler Thromb Vasc Biol,2005,25(7):1401-1407.
  • 7[7]Varo N,Libby P,Nuzzo R,et al.Elevated release of sCD40L from platelets of diabetic patients by thrombin,glucose and advanced glycation end products[J].Diab Vasc Dis Res,2005,2(2):81-87.
  • 8[8]Tan KC,Chow WS,Tam S,et al.Association between acute-phase reactants and advanced glycation end products in type 2 diabetes[J].Diabetes Care,2004,27(1):223-228.
  • 9[9]Basta G,Lazzerini G,Massaro M,et al.Advanced glycation end products activate endothelium through signal-transduction receptor RAGE:a mechanism for amplification of inflammatory responses[J].Circulation,2002,105(7):816-822.
  • 10[10]Tan KC,Chow WS,Ai VH,et al.Advanced glycation end products and endothelial dysfunction in type 2 diabetes[J].Diabetes Care,2002,25(6):1055-1059.

共引文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部